false
OasisLMS
Catalog
SCCM Resource Library
Stem Cell Therapy in Ischemic Stroke
Stem Cell Therapy in Ischemic Stroke
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Neeraj Bajatia, Chief of Neurocritical Care at the University of Maryland School of Medicine, discusses the use of stem cell therapy in ischemic stroke. Stroke is a leading cause of death and disability worldwide, and the current focus of stroke therapy is on neuroprotection and neurorepair. Stem cell therapy has the potential to prevent tissue damage and promote the repair of damaged tissue, leading to functional recovery. Different types of stem cells, such as neural stem cells, hematopoietic stem cells, and mesenchymal stem cells, have shown promise in stroke therapy. The success of stem cell therapy depends on factors such as the source of stem cells, route of administration, timing of administration, and outcome measurement. Clinical studies have shown that stem cell transplantation in stroke patients is generally safe and may lead to improvements in motor function. However, further research is needed to determine the optimal target population and treatment regimen for stem cell therapy in stroke. Numerous clinical trials are currently underway to explore the potential of stem cell therapy in stroke treatment.
Asset Subtitle
Neuroscience, Transplant, 2022
Asset Caption
This session will review the exciting frontier of stem cell therapy for acute neurological injuries, including global anoxic injury, stroke, and spinal cord injury.
Meta Tag
Content Type
Presentation
Knowledge Area
Neuroscience
Knowledge Area
Transplant
Knowledge Level
Advanced
Membership Level
Select
Tag
Stroke
Tag
Stem Cells
Year
2022
Keywords
stem cell therapy
ischemic stroke
neuroprotection
functional recovery
clinical trials
×
Please select your language
1
English